CCND2-AS1

Across TCGA pan-cancer cohorts, CCND2-AS1 RNA is linked to patient survival in 21 of 34 cancer types, making it the most broadly survival-associated CCND2-AS1 data layer.

The strongest signal is observed in uterine carcinosarcoma (UCS), where higher CCND2-AS1 RNA is associated with better overall survival. In most high-consensus cancer types, elevated CCND2-AS1 expression acts as an unfavorable survival marker, although some lineages such as UCS and KIRP show a favorable association.

UCS, KIRP, and ACC are the cancer types where CCND2-AS1 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
UCS	OS	Quartile	III,IV	0.745	0.198	<.001	70	view →
KIRP	DFS	Median	II,III,IV	0.891	0.251	.001	64	view →
ACC	OS	Quartile	II,III,IV	1.000	0.357	.005	53	view →
ESCA	OS	Tertile	III,IV	0.660	0.282	<.001	52	view →
SKCM	OS	Median	III,IV	0.876	0.776	.010	29	view →
MESO	OS	Median	All	0.678	0.421	.001	16	view →
LUAD	OS	Quartile	All	0.787	0.598	.014	12	view →
LGG	OS	Median	All	0.588	0.412	.011	11	view →
LAML	DFS	Median	All	0.499	0.290	.037	10	view →
BRCA	OS	Quartile	All	0.951	0.905	.017	8	view →
CESC	OS	Median	IV	0.787	0.422	.041	6	view →
CHOL	DFS	Tertile	III,IV	0.154	0.529	.024	6	view →

Pink = unfavorable, green = favorable. Showing the 12 strongest of 21 lineages.

CCND2-AS1–UCS (OS)

Open the UCS breakdown →